Stem cell marker CD271 is expressed by vasculogenic mimicryforming uveal melanoma cells in three-dimensional cultures

Molecular Vision

Volumn 18, Issue , 2012, Pages 588-592

  Valyi Nagy, Klara ^a   Kormos, Bernadett ^a   Ali, Mohamed ^a   Shukla, Deepak ^a   Valyi Nagy, Tibor ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTER OF DIFFERENTIATION 271; NERVE GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER STEM CELL; CELL CULTURE; CELL GROWTH; CELL SUBPOPULATION; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; MELANOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UVEA MELANOMA;

CELL CULTURE TECHNIQUES; DRUG RESISTANCE, NEOPLASM; EYE; EYE NEOPLASMS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; PHENOTYPE; RECEPTORS, NERVE GROWTH FACTOR; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 84859071945     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Schatton T, Frank MH. Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res. 2008; 21:39-55. [PMID: 18353142]
2. Girouard SD, Murphy GF. Melanoma stem cells: not rare, but well done. Lab Invest 2011; 91:647-64. [PMID: 21445060]
3. Chandrasekaran S, De Louise LA. Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line. Biomaterials 2011; 32:9316-27. [PMID: 21917310]
4. Micera A, Lambiase A, Stampachiacchiere B, Bonini S, Bonini S, Levi-Schaffer F. Nerve growth factor and tissue repair remodeling: trkA (NGFR) and p75(NTR), two receptors one fate. Cytokine Growth Factor Rev 2007; 18:245-56. [PMID:17531524]
5. Rogers ML, Beare A, Zola H, Rush RA. CD 271 (P75 neurotrophin receptor). J Biol Regul Homeost Agents 2008; 22:1-6. [PMID: 18394312]
6. Chesa PG, Rettig WJ, Thomson TM, Old LJ, Melamed MR. Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues. J Histochem Cytochem 1988; 36:383-9. [PMID: 2831267]
7. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, Butler PD, Yang GP, Joshua B, Kaplan MJ, Longaker MT, Weissman IL. Human melanomainitiating cells express neural crest nerve growth factor receptor CD271. Nature 2010; 466:133-7. [PMID: 20596026]
8. Civenni G, Walter A, Kobert N, Mihic-Probst D, Zipser M, Belloni B, Seifert B, Moch H, Dummer R, van den Broek M, Sommer L. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res 2011; 71:3098-109. [PMID:21393506]
9. Döme B, Hendrix MJ, Paku S, Tóvári J, Tímár J. Alternative vascularization mechanisms in cancer. Pathology and therapeutic implications. Am J Pathol 2007; 170:1-15. [PMID: 17200177]
10. Folberg R, Pe'er J, Gruman LM, Woolson RF, Jeng G, Montague PR, Moninger TO, Yi H, Moore KC. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched casecontrol study. Hum Pathol 1992; 23:1298-305. [PMID: 1427757]
11. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J, Gruman LM. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993; 100:1389-98. [PMID: 8371929]
12. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000; 156:361-81. [PMID: 10666364]
13. Folberg R, Leach L, Valyi-Nagy K, Lin AY, Apushkin MA, Ai Z, Barak V, Majumdar D, Pe'er J, Maniotis AJ. Modeling the behavior of uveal melanoma in the liver. Invest Ophthalmol Vis Sci 2007; 48:2967-74. [PMID: 17591861]
14. Folberg R, Maniotis AJ. Vasculogenic mimicry. APMIS 2004; 112:508-25. [PMID: 15563313]
15. Ghosh S, Spagnoli GC, Martin I, Ploegert S, Demougin P, Heberer M, Reschner A. Three-dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study. J Cell Physiol 2005; 204:522-31. [PMID: 15744745]
16. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 2003; 3:411-21. [PMID: 12778131]
17. Frank NY, Schatton T, Kim S, Zhan Q, Wilson BJ, Ma J, Saab KR, Osherov V, Widlund HR, Gasser M, Waaga-Gasser AM, Kupper TS, Murphy GF, Frank MH. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res 2011; 71:1474-85. [PMID: 21212411]
18. Valyi-Nagy K, Dosa S, Kovacs SK, Bacsa S, Voros A, Shukla D, Folberg R, Valyi-Nagy T. Identification of virus resistant tumor cell subpopulations in three-dimensional uveal melanoma cultures. Cancer Gene Ther 2010; 17:223-34. [PMID: 19893596]
19. Valyi-Nagy K, Voros A, Gagyi A, Valyi-Nagy T. Increased Resistance of Vasculogenic Mimicry-Forming Uveal Melanoma Cells against Cytotoxic Agents in Three-Dimensional Cultures, Research on Melanoma-A Glimpse into Current Directions and Future Trends. Mandi Murph (Ed.), InTech. 2011; Chapter 18. p. 377-392. Available at: http://www.intechopen.com/articles/show/title/increasedresistance-of-vasculogenic-mimicry-forming-uvealmelanoma-cells-against-cytotoxic-agents-i
20. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LMG, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999; 155:739-52. [PMID: 10487832]
21. Maniotis AJ, Valyi-Nagy K, Karavitis J, Moses J, Boddipali JV, Wang Y, Nuñez R, Setty S, Arbieva Z, Bissell MJ, Folberg R. Chromatin organization measured by Alu I restriction enzyme changes with malignancy and is regulated by the extracellular matrix and the cytoskeleton. Am J Pathol 2005; 166:1187-203. [PMID: 15793298]
22. Folberg R, Kadkol S, Frenkel S, Valyi-Nagy K, Jager MJ, Pe'er J, Maniotis AJ. Authenticating cell lines in ophthalmic research laboratories. Invest Ophthalmol Vis Sci 2008; 49:4697-701. [PMID: 18689700]
23. Valyi-Nagy K, Folberg R, Valyi-Nagy T, Maniotis AJ. Susceptibility of uveal melanoma to herpes simplex virus type1: the role of tumor invasiveness, the extracellular matrix and chromatin sequestration. Exp Eye Res 2007; 84:991-1000. [PMID: 17386925]
24. Jacks T, Weinberg RA. Taking the study of cancer cell survival to a new dimension. Cell 2002; 111:923-5. [PMID:12507419]
25. Schmidmaier R, Baumann P. Anti-adhesion evolves to a promising therapeutic concept in oncology. Curr Med Chem 2008; 15:978-90. [PMID: 18393855]
26. Vescio RA, Redfern CH, Nelso TJ, Udoretz S, Stern PH, Hoffman RM. In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Proc Natl Acad Sci USA 1987; 84:5029-33. [PMID:3474637]
27. Xu F, Burg KJL. Three-dimensional polymeric systems for cancer cell studies. Cytotechnology 2007; 54:135-43. [PMID:19003005]
28. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005; 65:9328-37. [PMID: 16230395]
29. Chang SH, Worley LA, Onken MD, Harbour JW. Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res 2008; 18:191-200. [PMID: 18477893]
30. Thill M, Berna MJ, Grierson R, Reinhart I, Voelkel T, Piechaczek C, Galambos P, Jager MJ, Richard G, Lange C, Gehling UM. Expression of CD133 and other putative stem cell markers in uveal melanoma. Melanoma Res 2011; 21:405-16. [PMID: 21900792]
31. Ward RJ, Dirks PB. Cancer stem cells: at the headwaters of tumor development. Annu Rev Pathol 2007; 2:175-89. [PMID: 18039097]